{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T15:00:25Z","timestamp":1764687625669},"reference-count":79,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/j.ejim.2013.09.005","type":"journal-article","created":{"date-parts":[[2013,10,9]],"date-time":"2013-10-09T16:30:28Z","timestamp":1381336228000},"page":"25-30","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities"],"prefix":"10.1016","volume":"25","author":[{"given":"Paolo","family":"Prandoni","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofia","family":"Barbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Milan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Vedovetto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raffaele","family":"Pesavento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2013.09.005_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-125-1-199607010-00001","article-title":"The long-term clinical course of acute deep venous thrombosis","volume":"125","author":"Prandoni","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0010","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1626 patients","volume":"91","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2013.09.005_bb0015","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1056\/NEJM199506223322501","article-title":"A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism","volume":"332","author":"Schulman","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0020","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/archinte.160.6.769","article-title":"Recurrent venous thromboembolism after deep vein thrombosis. Incidence and risk factors","volume":"1260","author":"Hansson","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0025","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0140-6736(03)14111-6","article-title":"Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study","volume":"362","author":"Baglin","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.09.005_bb0030","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1161\/01.CIR.0000079162.69615.0F","article-title":"Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia","volume":"108","author":"Palareti","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.09.005_bb0035","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.09.005_bb0040","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1161\/01.CIR.103.20.2453","article-title":"Comparison of 3 and 6months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12weeks of therapy after isolated calf deep vein thrombosis","volume":"103","author":"Pinede","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.09.005_bb0045","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1056\/NEJM199903253401201","article-title":"A comparison of three months of anticoagulation with extended anticoagulation for a first episode of idiopathic venous thromboembolism","volume":"340","author":"Kearon","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0050","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1056\/NEJM200107193450302","article-title":"Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis","volume":"345","author":"Agnelli","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0055","doi-asserted-by":"crossref","first-page":"19","DOI":"10.7326\/0003-4819-139-1-200307010-00008","article-title":"Extended oral anticoagulant therapy after a first episode of pulmonary embolism","volume":"139","author":"Agnelli","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0060","doi-asserted-by":"crossref","first-page":"540386","DOI":"10.1155\/2010\/540386","article-title":"Different finite durations of anticoagulation and outcomes following idiopathic venous thromboembolism: a meta-analysis","volume":"2010","author":"Holley","year":"2010","journal-title":"Thromb"},{"key":"10.1016\/j.ejim.2013.09.005_bb0065","doi-asserted-by":"crossref","first-page":"d3036","DOI":"10.1136\/bmj.d3036","article-title":"Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants' data from seven trials","volume":"342","author":"Boutitie","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.09.005_bb0070","doi-asserted-by":"crossref","first-page":"4432","DOI":"10.1182\/blood-2008-06-163279","article-title":"Influence of thrombophilia on risk of recurrent venous thromboembolism while on warfarin: results from a randomized trial","volume":"112","author":"Kearon","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.005_bb0075","first-page":"695","article-title":"The risk of recurrent venous thromboembolism in patients with inherited deficiency of natural anticoagulants antithrombin, protein C and protein S","volume":"91","author":"De Stefano","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2013.09.005_bb0080","first-page":"566","article-title":"Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism","volume":"80","author":"Eichinger","year":"1998","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0085","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1056\/NEJM200008173430702","article-title":"High plasma levels of factor VIII and the risk of recurrent venous thromboembolism","volume":"343","author":"Kyrle","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0090","first-page":"85","article-title":"6 versus 30months anticoagulation for recurrent venous thrombosis in patients with high factor VIII","volume":"88","author":"Eischer","year":"2008","journal-title":"Ann Hematol"},{"key":"10.1016\/j.ejim.2013.09.005_bb0095","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1046\/j.1538-7836.2003.00038.x","article-title":"The risks of recurrent venous thromboembolism among patients with high factor IX levels","volume":"1","author":"Weltermann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0100","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1001\/jama.2009.853","article-title":"Predictive value of factor V Leiden and prothrombin G20210A in adults with venous thromboembolism and in family members of those with a mutation: a systematic review","volume":"301","author":"Segal","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.09.005_bb0105","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/CIRCULATIONAHA.109.906347","article-title":"Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A","volume":"121","author":"Lijfering","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.09.005_bb0110","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.amjmed.2005.04.043","article-title":"Family history for venous thromboembolism and the risk for recurrence","volume":"119","author":"Hron","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0115","article-title":"Family history of venous thromboembolism (VTE) as a predictor for recurrent VTE in unprovoked VTE patients","author":"Gauthier","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0120","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0125","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/S0140-6736(06)69110-1","article-title":"Effect of patient's sex on risk of recurrent venous thromboembolism: a meta-analysis","volume":"368","author":"McRae","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ejim.2013.09.005_bb0130","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d813","article-title":"Risk of recurrence after venous thromboembolism in men and women: patient level meta-analysis","volume":"342","author":"Douketis","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.ejim.2013.09.005_bb0135","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood-2009-04-215418","article-title":"A lower risk of recurrent venous thrombosis in women compared to men is explained by sex-specific risk factors at time of first venous thrombosis in thrombophilic families","volume":"114","author":"Lijfering","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.005_bb0140","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1160\/TH09-10-0685","article-title":"Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study","volume":"104","author":"Le Gal","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0145","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1111\/j.1538-7836.2010.03958.x","article-title":"Patients with a first symptomatic unprovoked DVT are at higher risk of recurrent VTE than patients with a first unprovoked PE","volume":"8","author":"Kovacs","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0150","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1111\/j.1538-7836.2010.04022.x","article-title":"Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient level meta-analysis","volume":"8","author":"Baglin","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/MD.0b013e3181c29e31","article-title":"Age at first venous thromboembolism and risk of recurrence: a prospective cohort study","volume":"88","author":"Eischer","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ejim.2013.09.005_bb0160","first-page":"1046","article-title":"Venous thromboembolism in very elderly patients: findings from a prospective registry","volume":"91","author":"L\u00f3pez-Jim\u00e9nez","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2013.09.005_bb0165","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1001\/archinte.168.15.1678","article-title":"Overweight, obesity, and the risk of recurrent venous thromboembolism","volume":"68","author":"Eichinger","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0170","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.thromres.2012.08.296","article-title":"Lipid lowering drugs and the risk of recurrent venous thromboembolism","volume":"130","author":"Delluc","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejim.2013.09.005_bb0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/j.1538-7836.2006.01868.x","article-title":"Prediction of recurrent venous thromboembolism by the activated partial thromboplastin time","volume":"4","author":"Hron","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0180","doi-asserted-by":"crossref","first-page":"e38705","DOI":"10.1371\/journal.pone.0038705","article-title":"Hematocrit and the risk of recurrent venous thrombosis: a prospective cohort study","volume":"7","author":"Eischer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2013.09.005_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2011.09018.x","article-title":"Elevated albuminuria associated with increased risk of recurrent venous thromboembolism: results of a population-based cohort study","author":"van Schouwenburg","year":"2012","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.09.005_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/j.1538-7836.2012.04884.x","article-title":"Impaired tissue factor pathway inhibitor function is associated with recurrent venous thromboembolism in patients with first unprovoked deep venous thrombosis","author":"Winckers","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0195","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1160\/TH04-07-0445","article-title":"\u201cProC Global\u201d: a functional screening test that predicts recurrent venous thromboembolism","volume":"93","author":"Grand'maison","year":"2005","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0200","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/jama.296.4.397","article-title":"Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation","volume":"296","author":"Hron","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.09.005_bb0205","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1111\/j.1538-7836.2008.03117.x","article-title":"High rate of unprovoked recurrent venous thrombosis is associated with high thrombin-generating potential in a prospective cohort study","volume":"6","author":"Besser","year":"2008","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0210","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0215","first-page":"515","article-title":"Normalization rates of compression ultrasonography in patients with a first episode of deep vein thrombosis of the lower limbs: association with recurrence and new thrombosis","volume":"87","author":"Piovella","year":"2002","journal-title":"Haematologica"},{"key":"10.1016\/j.ejim.2013.09.005_bb0220","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","article-title":"Residual venous thrombosis as predictive factor for recurrent venous thromboembolism in patients with proximal deep vein thrombosis: a systematic review","volume":"153","author":"Tan","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejim.2013.09.005_bb0225","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1258\/ar.2012.110697","article-title":"Long-term outcome of patients with persistent vascular obstruction on computed tomography pulmonary angiography 6months after acute pulmonary embolism","volume":"53","author":"Golpe","year":"2012","journal-title":"Acta Radiol"},{"key":"10.1016\/j.ejim.2013.09.005_bb0230","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-0037-1612936","article-title":"Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped","volume":"87","author":"Palareti","year":"2002","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0235","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jama.290.8.1071","article-title":"D-dimer levels and risk of recurrent venous thromboembolism","volume":"290","author":"Eichinger","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejim.2013.09.005_bb0240","doi-asserted-by":"crossref","first-page":"481","DOI":"10.7326\/0003-4819-149-7-200810070-00008","article-title":"Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism","volume":"149","author":"Verhovsek","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0245","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1538-7836.2009.03293.x","article-title":"Elevated D-dimer levels predict recurrence in patients with idiopathic venous thromboembolism: a meta-analysis","volume":"7","author":"Bruinstroop","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0250","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1111\/j.1538-7836.2005.01648.x","article-title":"The post-thrombotic syndrome: risk factors and impact on the course of thrombotic disease","volume":"3","author":"Stain","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0255","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1503\/cmaj.080493","article-title":"Identifying unprovoked thromboembolism patients at low risk for recurrence who can discontinue anticoagulant therapy","volume":"179","author":"Rodger","year":"2008","journal-title":"CMAJ"},{"key":"10.1016\/j.ejim.2013.09.005_bb0260","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1161\/CIRCULATIONAHA.109.925214","article-title":"Risk assessment of recurrence in patients with unprovoked deep vein thrombosis or pulmonary embolism. The Vienna Prediction Model","volume":"121","author":"Eichinger","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ejim.2013.09.005_bb0265","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/j.1538-7836.2012.04735.x","article-title":"Predicting disease recurrence in patients with previous unprovoked venous thromboembolism. A proposed prediction score (DASH)","volume":"10","author":"Tosetto","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0270","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1160\/TH12-05-0353","article-title":"Clinical scores to predict recurrence risk of venous thromboembolism","volume":"108","author":"Kyrle","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0275","series-title":"American College of Chest Physicians Evidence-based Clinical Practice Guidelines","first-page":"e419-94S","article-title":"Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis","volume":"141","author":"Kearon","year":"2012"},{"key":"10.1016\/j.ejim.2013.09.005_bb0280","doi-asserted-by":"crossref","first-page":"766","DOI":"10.7326\/0003-4819-147-11-200712040-00007","article-title":"The risk for fatal pulmonary embolism after discontinuing anticoagulant therapy for venous thromboembolism","volume":"147","author":"Douketis","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0285","doi-asserted-by":"crossref","first-page":"893","DOI":"10.7326\/0003-4819-139-11-200312020-00007","article-title":"Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism. A meta-analysis","volume":"139","author":"Linkins","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0290","doi-asserted-by":"crossref","first-page":"578","DOI":"10.7326\/0003-4819-152-9-201005040-00008","article-title":"Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism","volume":"152","author":"Carrier","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0295","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1001\/archinternmed.2007.69","article-title":"Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study","volume":"168","author":"Spencer","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0300","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1111\/j.1538-7836.2010.04039.x","article-title":"Major bleeding as a predictor of mortality in patients with venous thromboembolism","volume":"8","author":"Prandoni","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0305","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa035029","article-title":"Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism","volume":"348","author":"Ridker","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0310","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1056\/NEJMoa035422","article-title":"Comparison of low-intensity warfarin therapy with conventional-intensity warfarin therapy for long-term prevention of recurrent venous thromboembolism","volume":"349","author":"Kearon","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0315","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1056\/NEJMoa054444","article-title":"D-dimer testing to determine the duration of anticoagulation therapy","volume":"355","author":"Palareti","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0320","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1182\/blood-2009-08-237354","article-title":"Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study","volume":"115","author":"Cosmi","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.005_bb0325","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","article-title":"Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial","volume":"150","author":"Prandoni","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0330","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1182\/blood-2008-01-131656","article-title":"Residual vein thrombosis to establish duration of anticoagulation after a first episode of deep vein thrombosis: the \u201cDACUS\u201d study","volume":"112","author":"Siragusa","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2013.09.005_bb0335","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1114238","article-title":"Aspirin for preventing the recurrence of venous thromboembolism","volume":"366","author":"Becattini","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0340","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1056\/NEJMoa1210384","article-title":"Low-dose aspirin for preventing recurrent venous thromboembolism","volume":"367","author":"Brighton","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0345","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1538-7836.2012.04635.x","article-title":"Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis","volume":"10","author":"Warkentin","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0350","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1111\/j.1538-7836.2012.04865.x","article-title":"Aspirin and recurrent venous thromboembolism in patients with symptomatic atherosclerosis. Retrospective cohort study","volume":"10","author":"Milan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0355","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1538-7836.2009.03279.x","article-title":"Arterial cardiovascular events, statins, low dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study","volume":"7","author":"S\u00f8rensen","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejim.2013.09.005_bb0360","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0365","series-title":"Proc ASH","article-title":"A randomized trial of dabigatran versus warfarin in the treatment of acute venous thromboembolism (RE-COVER II)","volume":"118","author":"Schulman","year":"2011"},{"key":"10.1016\/j.ejim.2013.09.005_bb0370","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1113697","article-title":"Extended use of dabigatran, warfarin, or placebo in venous thromboembolism","volume":"368","author":"Schulman","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0375","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"The Einstein Investigators","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0380","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"The Einstein Investigators","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0385","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0390","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejim.2013.09.005_bb0395","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","author":"The Hokusai-VTE Investigators","year":"2013","journal-title":"N Engl J Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620513009436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T15:10:58Z","timestamp":1564499458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620513009436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1]]},"references-count":79,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S0953620513009436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2013.09.005","relation":{},"ISSN":["0953-6205"],"issn-type":[{"value":"0953-6205","type":"print"}],"subject":[],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of recurrent thromboembolic disorders in patients with unprovoked venous thromboembolism: New scenarios and opportunities","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2013.09.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}